Drug developers for rare diseases require a partner that understands the unique, complex needs of orphan drug development. Q2
Solutions’ industry-leading scientists partner with you to optimize your study design and accelerate regulatory approval.
With global end-to-end laboratory solutions, we offer assay development services, immunogenicity testing, genomic solutions, efficacy monitoring, project management and data management to meet your orphan drug and vaccine development needs.
Learn more about our orphan drug and vaccine development capabilities for rare diseases: